EUSA Pharma (Denmark) ApS: Financial statements 2023
CVR: 39055988
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. That is a decrease of 36.5% compared with the year before. Equity in the 2023 report amounted to DKK 1,644,740. The solvency ratio was 80.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,928,889
- Profit/Loss
- DKK 141,012
- Equity
- DKK 1,644,740
- Total Assets
- DKK 2,038,537
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.9 mio. | 141 t. | 1.6 mio. | 1 |
| 2022 | - | 3 mio. | 198 t. | 1.5 mio. | 2 |
| 2021 | - | 9.4 mio. | 483 t. | 1.3 mio. | 5 |
| 2020 | - | 9.8 mio. | 607 t. | 823 t. | 6 |
| 2019 | - | 2.1 mio. | 228 t. | 215 t. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
EUSA Pharma (Denmark) ApS has published its annual report for 2022. Gross profit came to DKK 3,037,780, and the net result was DKK 198,473.
About EUSA Pharma (Denmark) ApS
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 19 December 2024. The company was registered under the industry Reklamebureauer. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity in the 2023 report amounted to DKK 1,644,740.